{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:21:01Z","timestamp":1788434461081,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04716-9","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:05:19Z","timestamp":1784556319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Guillain\u2013Barr\u00e9 syndrome and its variants during COVID-19 pandemic: a retrospective study in Iran"],"prefix":"10.1186","volume":"26","author":[{"given":"Maryam Abedini","family":"Parizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somaye Ebrahimi","family":"Nejhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6088-6120","authenticated-orcid":false,"given":"Hossein Ali Ebrahimi","family":"Meimand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdiyeh","family":"khazaneha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"4","key":"4716_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3348\/kjr.2020.0112","volume":"21","author":"J Wei","year":"2020","unstructured":"Wei J, Xu H, Xiong J, Shen Q, Fan B, Ye C, et al. 2019 novel coronavirus (COVID-19) pneumonia: serial computed tomography findings. Korean J Radiol. 2020;21(4):501.","journal-title":"Korean J Radiol"},{"issue":"10223","key":"4716_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"key":"4716_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","volume":"24","author":"MA Shereen","year":"2020","unstructured":"Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses. J Adv Res. 2020;24:91\u20138.","journal-title":"J Adv Res"},{"issue":"1","key":"4716_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/jmv.26265","volume":"93","author":"J Dibner","year":"2021","unstructured":"Dibner J. Fecal-oral transmission of COVID\u201019: could hypochlorhydria play a role? J Med Virol. 2021;93(1):166.","journal-title":"J Med Virol"},{"key":"4716_CR5","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard [Internet]. 2023 [cited 2023 Feb 1]. Available from: https:\/\/covid19.who.int\/"},{"key":"4716_CR6","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard, Islamic Republic of Iran [Internet]. 2023 [cited 2023 Feb 1]. Available from: https:\/\/covid19.who.int\/region\/emro\/country\/ir"},{"issue":"10280","key":"4716_CR7","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","volume":"397","author":"N Shahrizaila","year":"2021","unstructured":"Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barr\u00e9 syndrome. Lancet. 2021;397(10280):1214\u201328.","journal-title":"Lancet"},{"issue":"5","key":"4716_CR8","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1212\/CON.0000000000000929","volume":"26","author":"KA Sheikh","year":"2020","unstructured":"Sheikh KA. Guillain-barr\u00e9 syndrome. Contin Lifelong Learn Neurol. 2020;26(5):1184\u2013204.","journal-title":"Contin Lifelong Learn Neurol"},{"issue":"3","key":"4716_CR9","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s10072-021-05562-y","volume":"43","author":"M Hosseininezhad","year":"2022","unstructured":"Hosseininezhad M, Khatami SS, Saadat S, Asghari M, Ghovvati Choshal H, Hooshmand Marvasti A, et al. Ten years evaluation of epidemiology-and mortality-related factors in adults and children with Guillain-Barr\u00e9 syndrome in the North of Iran. Neurol Sci. 2022;43(3):1929\u201338.","journal-title":"Neurol Sci"},{"key":"4716_CR10","doi-asserted-by":"crossref","unstructured":"Dalakas MC. Pathogenesis of immune-mediated neuropathies. Biochim Et Biophys Acta (BBA)-Molecular Basis Disease. 2015;1852(4):658\u201366.","DOI":"10.1016\/j.bbadis.2014.06.013"},{"issue":"5","key":"4716_CR11","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1212\/CON.0000000000000922","volume":"26","author":"ZN London","year":"2020","unstructured":"London ZN. A structured approach to the diagnosis of peripheral nervous system disorders. CONTINUUM: Lifelong Learn Neurol. 2020;26(5):1130\u201360.","journal-title":"CONTINUUM: Lifelong Learn Neurol"},{"issue":"4","key":"4716_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/mus.27024","volume":"62","author":"JB Caress","year":"2020","unstructured":"Caress JB, Castoro RJ, Simmons Z, Scelsa SN, Lewis RA, Ahlawat A, et al. COVID-19\u2013associated Guillain\u2010Barr\u00e9 syndrome: the early pandemic experience. Muscle Nerve. 2020;62(4):485\u201391.","journal-title":"Muscle Nerve"},{"key":"4716_CR13","doi-asserted-by":"publisher","first-page":"577719","DOI":"10.1016\/j.jneuroim.2021.577719","volume":"360","author":"WM Oo","year":"2021","unstructured":"Oo WM, Giri P, de Souza A, AstraZeneca. COVID-19 vaccine and Guillain-Barr\u00e9 syndrome in tasmania: A causal link? J Neuroimmunol. 2021;360:577719.","journal-title":"J Neuroimmunol"},{"key":"4716_CR14","doi-asserted-by":"crossref","unstructured":"Pimentel V, Luchsinger VW, Carvalho GL, Alcar\u00e1 AM, Esper NB, Marinowic D, Zanirati G, da Costa JC. Guillain\u2013Barr\u00e9 syndrome associated with COVID-19: a systematic review. Brain, behavior, & immunity-health. 2023;28:100578.","DOI":"10.1016\/j.bbih.2022.100578"},{"issue":"2","key":"4716_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10072-022-06429-6","volume":"44","author":"F Martinelli-Boneschi","year":"2023","unstructured":"Martinelli-Boneschi F, Colombo A, Bresolin N, Sessa M, Bassi P, Grampa G, et al. COVID-19-associated Guillain-Barr\u00e9 syndrome in the early pandemic experience in Lombardia (Italy). Neurol Sci. 2023;44(2):437\u201346.","journal-title":"Neurol Sci"},{"issue":"2","key":"4716_CR16","doi-asserted-by":"publisher","first-page":"e2253845","DOI":"10.1001\/jamanetworkopen.2022.53845","volume":"6","author":"WE Abara","year":"2023","unstructured":"Abara WE, Gee J, Marquez P, Woo J, Myers TR, DeSantis A, et al. Reports of Guillain-Barr\u00e9 syndrome after COVID-19 vaccination in the united States. JAMA Netw Open. 2023;6(2):e2253845\u20132253845.","journal-title":"JAMA Netw Open"},{"key":"4716_CR17","doi-asserted-by":"crossref","unstructured":"Ghazanfar H, Qazi R, Ghazanfar A, Iftekhar S. Significance of Brightoncriteria in the early diagnosis and management of Guillain-Barr\u00e9 syndrome. Cureus. 2020 May 27;12(5):e8318.","DOI":"10.7759\/cureus.8318"},{"key":"4716_CR18","doi-asserted-by":"crossref","unstructured":"Preston DC, Shapiro BE. Electromyography and neuromuscular disorderse-book: clinical-electrophysiologic correlations (Expert Consult-Online). Elsevier Health Sciences; 2012 Dec 1.","DOI":"10.1016\/B978-1-4557-2672-1.00016-7"},{"issue":"6","key":"4716_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/mus.880120602","volume":"12","author":"JW Albers","year":"1989","unstructured":"Albers JW, Kelly JJ Jr. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve Off J Am Assoc Electrodiagn Med. 1989;12(6):435\u201351.","journal-title":"Muscle Nerve Off J Am Assoc Electrodiagn Med"},{"issue":"9","key":"4716_CR20","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1212\/WNL.37.9.1493","volume":"37","author":"RD Fross","year":"1987","unstructured":"Fross RD, Daube JR. Neuropathy in the miller fisher syndrome: clinical and electrophysiologic findings. Neurology. 1987;37(9):1493.","journal-title":"Neurology"},{"issue":"1","key":"4716_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5144\/0256-4947.2006.22","volume":"26","author":"MA Arami","year":"2006","unstructured":"Arami MA, Yazdchi M, Khandaghi R. Epidemiology and characteristics of Gillain-Barre syndrome in the Northwest of Iran. Ann Saudi Med. 2006;26(1):22\u20137.","journal-title":"Ann Saudi Med"},{"key":"4716_CR22","doi-asserted-by":"publisher","unstructured":"Tonekaboni SH, Mahmoudi S, Abdollah Gorji F, Nejad Biglari H, Taghdiri MM, Etemadi K, Ghofrani M, Karimi A, Rezaei Zadeh M. Epidemiology of Guillain-Barr\u00e9 syndrome in Iranian children aged 0\u201315 years (2008\u20132013). Iran J Child Neurol 2021 Fall;15(4):27\u201334. https:\/\/doi.org\/10.22037\/ijcn.v15i4.25087. PMID: 34782839; PMCID: PMC8570621.","DOI":"10.22037\/ijcn.v15i4.25087"},{"key":"4716_CR23","doi-asserted-by":"publisher","first-page":"0104","DOI":"10.15275\/rusomj.2014.0104","volume":"3","author":"HA Ebrahimi","year":"2014","unstructured":"Ebrahimi HA, Nakhaee N, Zahmatkesh R, Mirzaee M. Study of acute flaccid paralysis surveillance system in Kerman (Iran) for one decade. Russian Open Med J. 2014;3:0104.","journal-title":"Russian Open Med J"},{"issue":"2","key":"4716_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000184748","volume":"32","author":"A McGrogan","year":"2009","unstructured":"McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain-Barr\u00e9 syndrome worldwide. A systematic literature review. Neuroepidemiology. 2009;32(2):150\u201363. https:\/\/doi.org\/10.1159\/000184748. Epub 2008 Dec 17. PMID: 19088488.","journal-title":"Neuroepidemiology"},{"key":"4716_CR25","doi-asserted-by":"publisher","unstructured":"Wachira VK, Farinasso CM, Silva RB, da, Peixoto HM, de Oliveira MRF. (2022). Incidence of Guillain-Barr\u00e9 syndrome in the world between 1985 and 2020: a systematic Review. In SciELO Preprints. https:\/\/doi.org\/10.1590\/SciELOPreprints.4231","DOI":"10.1590\/SciELOPreprints.4231"},{"issue":"Pt 1","key":"4716_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria. Brain. 2014;137(Pt 1):33\u201343. [PubMed] [Reference list].","journal-title":"Brain"},{"issue":"5","key":"4716_CR27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1034\/j.1600-0404.2001.103005278.x","volume":"103","author":"M Koga","year":"2001","unstructured":"Koga M, Yuki N, Hirata K. Antecedent symptoms in Guillain-Barr\u00e9 syndrome: an important indicator for clinical and serological subgroups. Acta Neurol Scand. 2001;103(5):278\u201387. [PubMed] [Reference list].","journal-title":"Acta Neurol Scand"},{"key":"4716_CR28","unstructured":"Nguyen TP, Taylor RS. Guillain-Barre Syndrome. [Updated 2023 Feb 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532254\/"},{"issue":"1","key":"4716_CR29","first-page":"15","volume":"12","author":"Anahid Safari1, Afshin Borhani-Haghighi2","year":"2013","unstructured":"Anahid Safari1, Afshin Borhani-Haghighi2. Seyed Taghi Heydari3, Kamran bagheri Lankarani4, increased Guillain-Barre syndrome admissions in Shiraz, Southern Iran. Ir J Neurol. 2013;12(1):15\u20138.","journal-title":"Ir J Neurol"},{"key":"4716_CR30","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/cid\/ciu005","volume":"58","author":"C Vellozzi","year":"2014","unstructured":"Vellozzi C, Iqbal S, Broder K. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence. Clin Infect Dis. 2014;58:1149\u201355.","journal-title":"Clin Infect Dis"},{"key":"4716_CR31","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1001\/archinte.166.20.2217","volume":"166","author":"DN Juurlink","year":"2006","unstructured":"Juurlink DN, Stukel TA, Kwong J, et al. Guillain-Barr\u00e9 syndrome after influenza vaccination in adults: A Population-Based study. JAMA Intern Med. 2006;166:2217\u201321.","journal-title":"JAMA Intern Med"},{"key":"4716_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.32598\/CJNS.8.28.213.2","volume":"8","author":"A Besharati","year":"2022","unstructured":"Besharati A, Saberi A, Shirkouhi SG, Ashraf A, Hatamian H, Kenarsari HE, Andalib S. Guillain-Barr\u00e9 syndrome during the COVID-19 pandemic and pre-pandemic periods. Casp J Neurol Sci. 2022;8:33\u20138. [Google Scholar] [CrossRef].","journal-title":"Casp J Neurol Sci"},{"key":"4716_CR33","unstructured":"Mazaheri S, Rezaie AA, Hossein Zadeh A. The Ten Years Survey on Clinical and Epidemiologic Features of Guillain-Barre Syndrome in Sina Hospital, Hamadan, Iran. Avicenna J Clin Med. 2007; 14 (2):56\u201360 URL: http:\/\/sjh.umsha.ac.ir\/article-1-432-en.html"},{"key":"4716_CR34","doi-asserted-by":"crossref","unstructured":"Boostani R, Ramezanzadeh F, Saeidi M, Khodabandeh M. A follow-up study on Guillain-Barre syndrome and validation of Brighton criteria. Iranian Journal of Neurology. 2019;18(2):64f.","DOI":"10.18502\/ijnl.v18i2.1290"},{"key":"4716_CR35","unstructured":"Abbas Rjaberi, *1 AM. Ali Mossallaiepoor2, Mohammad mehdi Ebrahimi2, Sahar Khazforoosh2, Shadan Shirazi zade mehraban2, Shideh Aramesh fard3, Parivash Ahmadfard2, Javad Salami, N Mousaei. The Epidemiologic, Clinical and Laboratory Findings of Patients with Guillain Barre\u00b4 Syndrome in Southern Iran Since 2007 to 2012. JABS. 2013;3(4):343\u20137."},{"key":"4716_CR36","doi-asserted-by":"publisher","first-page":"117263","DOI":"10.1016\/j.jns.2020.117263","volume":"420","author":"S Sriwastava","year":"2021","unstructured":"Sriwastava S, Kataria S, Tandon M, Patel J, Patel R, Jowkar A, Daimee M, Bernitsas E, Jaiswal P, Lisak RP. Guillain Barr\u00e9 syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series. J Neurol Sci. 2021;420:117263. Epub 2020 Dec 9. PMID: 33321326; PMCID: PMC7725056.","journal-title":"J Neurol Sci"},{"issue":"5","key":"4716_CR37","doi-asserted-by":"publisher","first-page":"703","DOI":"10.32598\/bcn.2021.3565.1","volume":"12","author":"N Karimi","year":"2021","unstructured":"Karimi N, Boostani R, Fatehi F, Panahi A, Okhovat AA, Ziaadini B, et al. Guillain-Barre syndrome and COVID-19 vaccine: A report of nine patients. BCN. 2021;12(5):703\u201310. http:\/\/bcn.iums.ac.ir\/article-1-2223-en.html.","journal-title":"BCN"},{"key":"4716_CR38","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s40120-021-00261-4","volume":"10","author":"Haruki Koike","year":"2021","unstructured":"Haruki Koike. Atsuro Chiba. Masahisa Katsuno. Emerging Infection, Vaccination, and Guillain\u2013Barre\u00b4 syndrome: A review. Neurol Ther. 2021;10:523\u201337. https:\/\/doi.org\/10.1007\/s40120-021-00261-4.","journal-title":"Neurol Ther"},{"issue":"5","key":"4716_CR39","first-page":"2152","volume":"27","author":"H Mahmoud","year":"2023","unstructured":"Mahmoud H, Alhathla A, El-Fiky A, Alghamdi MS, Alwafi R, El-Sayed MS, Thabet AA, Alkhateeb AM, Elgendy SR, Hegazy R, Darweesh A. Incidence of Guillain-Barr\u00e9 syndrome post COVID-19: a systematic review of case reports and case series. Eur Rev Med Pharmacol Sci. 2023;27(5):2152\u201364. doi: 10.26355\/eurrev_202303_31588. PMID: 36930515.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4716_CR40","doi-asserted-by":"crossref","first-page":"e11354","DOI":"10.1016\/j.heliyon.2022.e11354","volume":"8","author":"Carlos Quispe-icu\u00f1a","year":"2022","unstructured":"Carlos Quispe-icu\u00f1a. A b, Miguel Cabanillas-Lazo A b, Maria Eugenia Guerrero c, Franco Mauricio d, John Barja-Ore e, Frank Mayta-Tovalino global academic output on COVID-19 and Guillain-Barre syndrome: A bibliometric analysis. Heliyon. 2022;8:e11354.","journal-title":"Heliyon"},{"issue":"7","key":"4716_CR41","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.nrl.2018.03.021","volume":"36","author":"JM Aragon\u00e8s a","year":"2021","unstructured":"Aragon\u00e8s a JM, Alonsoc J, Celed\u00f3nc G, Alfonsoa SP. Roura b,d y A. Moreiraa. Incidencia y caracter\u00edsticas cl\u00ednicas del s\u00edndrome de Guillain-Barr\u00e9 en la comarca de Osona (Barcelona, Espana) \u02dc (2003\u20132016). Neurolog\u00eda. 2021;36(7):525\u201330.","journal-title":"Neurolog\u00eda"},{"key":"4716_CR42","unstructured":"Public Health Agency of. Sweden [cited 2022 Apr 11]. Available from: www.folkhalsomyndigheten.se"},{"key":"4716_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.118554","author":"E Dirandeh","year":"2021","unstructured":"Dirandeh E, Hatami H, Fatehi F, Heshmat R. Seasonal variation of Gillain-Barre syndrome in Iranian patients, A retrospective study. J Neurol Sci 429 Supplement Oct. 2021. https:\/\/doi.org\/10.1016\/j.jns.2021.118554.","journal-title":"J Neurol Sci 429 Supplement Oct"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04716-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04716-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04716-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:58:43Z","timestamp":1788433123000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04716-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4716"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04716-9","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"15 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. Informed consent was obtained from all participants or their legal guardians.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Afzalipour Hospital, Kerman University of Medical Sciences, approval ID; IR.KMU.AH.REC.1402.005. Written informed consent has been obtained from all the participants and for individuals younger than 16, consent to participate was obtained from their parents or legal guardians.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"561"}}